92 results
Page 3 of 5
8-K
EX-10.1
zly33p sf
29 Jan 20
BioPharmX and Timber Pharmaceuticals Announce Entry into Merger Agreement
4:33pm
8-K
EX-10.4
kpk3 w1kpru4mskrbm
29 Jan 20
BioPharmX and Timber Pharmaceuticals Announce Entry into Merger Agreement
4:33pm
8-K
EX-10.3
dll so3hpue
29 Jan 20
BioPharmX and Timber Pharmaceuticals Announce Entry into Merger Agreement
4:33pm
425
EX-10.1
59h8z6w4ui3 kiw5pa
29 Jan 20
Business combination disclosure
4:31pm
425
EX-10.2
6fvbcdh
29 Jan 20
Business combination disclosure
4:31pm
425
EX-10.4
zu2u1zp5ztgzww
29 Jan 20
Business combination disclosure
4:31pm
425
EX-10.3
bq3lzy8 9k67b1btpnlx
29 Jan 20
Business combination disclosure
4:31pm
8-K
EX-10.1
fq0r7v oa
17 Jul 19
BioPharmX Announces Steven M. Bosacki Joins the Company as Chief Operating Officer
4:12pm
8-K
EX-10.2
4p1qhi2 24
21 Mar 19
BioPharmX Announces $3.9 Million Offering
4:16pm
8-K
EX-10.1
dx8ar9azufs2mo0op
21 Mar 19
BioPharmX Announces $3.9 Million Offering
4:16pm
8-K
EX-10.1
0fmujylje435w4da5bdy
21 Nov 18
Entry into a Material Definitive Agreement
8:30am
8-K
EX-10.1
x1hbjul
31 Oct 18
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-10.1
ry09b y6z9nb0hrun32z
13 Sep 18
BioPharmX Corporation Announces David S. Tierney, MD Joined the Company as Chief Executive Officer
12:00am
8-K
EX-10.1
yea3y
23 Oct 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
ic44uhokuy7v p6gho
24 Jul 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
x1wny ai3cjju0kxuipe
26 Apr 17
BioPharmX Announces $5.0 Million Offering
12:00am
8-K
EX-10.1
1pu8eids5t4z
26 Apr 17
BioPharmX Announces $5.0 Million Offering
12:00am